Definitive Healthcare Corp. (DH) SEC Filings & Earnings Calls

Potential change of control could lead to significant strategic and operational changes; TRA waiver reduces but does not eliminate transaction risks.

“TRA will terminate in accordance with its terms and the TRA Parties agree to take such actions as are reasonably necessary to effect such termination upon the consummation of a Qualifying Change of Control” · word for word

Proposed acquisition may not be consummated

“No assurance can be given that any definitive agreement will be entered into, that the Proposed Transaction will be consummated, or that the Proposed Transaction will be consummated on the terms set forth in the Proposal.” · word for word

Proposed acquisition may not be consummated

“No assurance can be given that any definitive agreement will be entered into, that the Proposed Transaction will be consummated, or that the Proposed Transaction will be consummated on the terms set forth in the Proposal.” · word for word

Limited information; no details on compensation or role, so impact uncertain.

“Only exhibit reference, no substantive terms disclosed.”

Deal may not close; non-binding proposal subject to due diligence and financing.

“non-binding proposal” · word for word

Proposed acquisition may not be consummated

“No assurance can be given that any definitive agreement will be entered into, that the Proposed Transaction will be consummated, or that the Proposed Transaction will be consummated on the terms set forth in the Proposal.”

Proposed acquisition may not be consummated

“No assurance can be given that any definitive agreement will be entered into, that the Proposed Transaction will be consummated, or that the Proposed Transaction will be consummated on the terms set forth in the Proposal.”

Revenue decline of 9% YoY indicates ongoing headwinds; guidance implies continued softness.

“Revenue was $55.2 million, a decrease of 9% from $60.8 million in Q2 2025; Q3 2026 guidance $54-55M vs $55.2M in Q2.” · word for word

Nasdaq delisting risk

“closing bid price of the Company’s common stock was below $1.00 per share for 30 consecutive business days” · word for word

Goodwill fully impaired

“recorded a non-cash, pretax, goodwill impairment charge of $ 197.2 million” · word for word

Revenue decline

“Revenue $ 55,195 $ 60,750” · word for word

Potential delisting from Nasdaq if bid price compliance not regained

“the Company no longer meets the minimum bid price requirement of $1.00 per share set forth in Nasdaq Listing Rule 5450(a)(1) for continued listing on The Nasdaq Global Select Market.” · word for word

Goodwill impairment risk

“$197.2 million in goodwill impairment charges recorded during the three months ended March 31, 2026” · word for word

Liquidity risk

“Net cash provided by operating activities was $11.6 million during the three months ended March 31, 2026, primarily as a result of a net loss of $192.4 million” · word for word

Goodwill impairment risk: $197.2M charge indicates potential overpayment for acquisitions.

“Net Loss, inclusive of goodwill impairment charges of $197.2 million, was $(192.4) million.” · word for word

Revenue decline: 6% YoY drop suggests competitive or market headwinds.

“Revenue was $55.9 million, a decrease of 6% from $59.2 million in Q1 2025.” · word for word

Equity dilution from share increase proposal

“To approve an amendment to the Definitive Healthcare Corp. 2021 Equity Incentive Plan ... to increase the number of shares ... by 15,000,000 from 30,972,789 to 45,972,789.” · word for word

Poor stock performance and negative net income

“Net Income (Loss) (Millions) ... 2025 ... (199.3) ... Total Shareholder Return ... 2025 ... 26.11”

Revenue decline and lower FY2026 guidance signal demand headwinds.

“FY2026 revenue guidance $220-226M vs FY2025 $241.5M.”

Goodwill impairment charges of $19.5M in Q4 and $196.1M in FY2025 indicate prior acquisition overpayment risk.

“Net Loss, inclusive of goodwill impairment charges of $19.5 million, was $(17.1) million.” · word for word

Demand Concentration Risk

“For the year ended December 31, 2025, we derived 96% of our revenue from subscription services, and we expect to continue to generate substantially all of our revenue from the sale of subscriptions to our platform.” · word for word

Macroeconomic Sensitivity

“difficult macroeconomic conditions have impacted our existing and prospective customers, which has in some cases resulted in longer deal cycles, more stringent approval processes and deferred purchasing decisions, and we expect this to continue until macroeconomic conditions improve.” · word for word

Competitive Pressure

“Such competition may result in pricing pressures, reduced profit margins or lost market share, or a failure to grow or maintain our market share, any of which could have a material adverse effect on our business, financial condition and results of operations.” · word for word

Management Turnover

“we have recently experienced significant management turnover, including our appointment of Kevin Coop as our Chief Executive Officer. Additionally, in November 2024, we announced that our former Chief Financial Officer, Richard Booth, would be leaving the Company effective June 1, 2025.” · word for word

Data Provider Dependency

“Our platform depends extensively upon continued access to and receipt of data from external sources, including real-time claims data, as well as data received from customers, strategic partners and various government and public records repositories.” · word for word

Macroeconomic conditions may increase funding requirements

“Macroeconomic conditions, including fluctuating inflation and high interest rates, could increase our anticipated funding requirements.” · word for word

Credit risk from cash held with financial institutions

“We hold cash with reputable financial institutions that often exceed federally insured limits.” · word for word

Inflation may not be fully offset by price increases

“If our costs were to become subject to significant inflationary pressures, we may not be able to fully offset higher costs through price increases” · word for word

Revenue decline of 4% YoY signals potential demand headwinds in healthcare commercial intelligence market.

“Revenue was $60.0 million, a decrease of 4% from $62.7 million in Q3 2024.” · word for word

Adjusted Net Income declined 37% YoY, indicating profitability pressure despite cost controls.

“Adjusted Net Income was $9.7 million, compared to $15.4 million in Q3 2024.” · word for word